Innovative Treatment for Scarred Vocal Cords by Local Injection of Autologous Stromal Vascular Fraction
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2019
Price : $35 *
At a glance
- Drugs ECCS 50 (Primary)
- Indications Scars
- Focus Adverse reactions
- Acronyms CELLCORDES
- 04 Mar 2019 Status changed from active, no longer recruiting to completed.
- 21 Aug 2018 New trial record
- 09 Aug 2018 According to a Cytori Therapeutics media release, the trial is being performed by Investigators at the Department of Oto-Rhino-Laryngology and Head and Neck Surgery of Aix-Marseille University and the Cell Therapy Laboratory of La Conception University Hospital, both of Marseille, France.